NEK3 and breast cancer: In addition, PRLR is mainly involved in JAK2–STAT5, Ras–Raf–MEK–MAPK, Ras–PI3K, Nek3–Vav2–Rac1, and other signaling pathways to regulate cell proliferation, migration, differentiation, and other processes [28,34,35,36,37], thus exerting effects on the development and progression of BC.